Stem Cell Players Giving Some Back (GERN, STEM, OPXA)

Posted in pre-market 
December 3rd, 2009

Geron Corporation (NASDAQ: GERN), StemCells Inc. (NASDAQ: STEM), and Opexa Therapeutics, Inc. (NASDAQ: OPXA) are all playing give-back this morning on the heels of monster gains yesterday due to the National Institutes of Health approving new embryonic stem cell lines.

At 8:39 AM EST we have GERN down 2.9% at $6.02 on 80,000 shares, STEM down 5.4% at $1.40 on 695,000 shares, and OPXA is down 10% at $2.86 on 35,000 shares.  As a reminder, the NIH did say that it would be making a new announcement on stem cell line approvals after 96 lines were submitted…. and that deadline is tomorrow, so these may all swing wildly yet again.

JON C. OGG

Comments are closed

-->